Cécile Moluçon‐Chabrot

Author

Centre Hospitalier Universitaire de Clermont-Ferrand ORCID

Also Known As

C Chabrot, C Moluçon-Chabrot, C. Chabrot, C. Molucon Chabrot, C. Molucon-Chabrot, C. Moluçon-Chabrot, C. Moluçon‐Chabrot, Cecile Chabrot, Cecile Molucon-Chabrot, Cecile Moluçon Chabrot

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Clermont-Ferrand Inserm Sorbonne Université Centre Hospitalier Universitaire de Grenoble Pitié-Salpêtrière Hospital

About

Cécile Moluçon‐Chabrot is an author at Centre Hospitalier Universitaire de Clermont-Ferrand specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	845
2	Health Sciences	1	1	25
3	Public Health	1	1	31
4	Cellular Therapies	1	1	23
5	Epidemiology	1	1	31

Cécile Moluçon‐Chabrot

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: Final analysis of the phase II ‘proof-of-concept’ iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network Carole Soussain, Sylvain Choquet, Marie Blonski, European Journal of Cancer Neuro-oncologyPrimary Vitreoretinal LymphomaLymphoid NeoplasiaOphthalmologyMedicine	2019	305
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study Caroline Houillier, Luc Taillandier, Sylvain Dureau, Journal of Clinical Oncology	2019	265
Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF) Laurence Millon, Raoul Herbrecht, Frédéric Grenouillet, Clinical Microbiology and Infection Early DiagnosisDiagnostic MycologyFrench Surveillance NetworkMedicineDiagnosis	2015	248
Management and outcome of primary CNS lymphoma in the modern era Caroline Houillier, Carole Soussain, Hervé Ghesquières, Neurology	2020	229
Lenalidomide in combination with intravenous rituximab (REVRI) in relapsed/refractory primary CNS lymphoma or primary intraocular lymphoma: a multicenter prospective ‘proof of concept’ phase II study of the French Oculo-Cerebral lymphoma (LOC) Network and the Lymphoma Study Association (LYSA) H. Ghesquières, Marion Chevrier, Mouna Laadhari, Annals of Oncology	2019	226
Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network Sophie Langner-Lemercier, Caroline Houillier, Carole Soussain, Neuro-Oncology	2016	189
High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years Emmanuel Gyan, Charles Foussard, Philippe B. Bertrand, Blood	2008	153
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study Caroline Houillier, Sylvain Dureau, Luc Taillandier, Journal of Clinical Oncology	2022	89
Intravenous high‐dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An <scp>LOC</scp> network study Marion Lam, Valérie Touitou, Sylvain Choquet, American Journal of Hematology Lymphoid NeoplasiaPrimary Vitreoretinal LymphomaIv Hd‐mtxOncologyOcular Disease	2021	62
Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary central nervous system lymphoma (PCNSL) in the elderly: a LOC network study Caroline Houillier, Hervé Ghesquières, Cécile Moluçon‐Chabrot, Journal of Neuro-Oncology Hematological MalignancyNeuro-oncologyLymphoid NeoplasiaOncologyMedicine	2017	56

Page 1